Product Description
The numbers don’t lie.
In Latisse (bimatoprost ophthalmic solution) 0.03% clinical trials, eyelashes grew:
- 25% Longer
- 106% Fuller
- 18% Darker
The success behind Latisse
In a 2001 study that included 278 adults, at week 16, patients had an average of 1.4 mm growth in length (25% increase) and a 106% increase in fullness and thickness of lashes.
FDA-approved
The first and only FDA-approved treatment to grow eyelashes for people with inadequate lashes.
Results typically seen in 16 weeks
The solution works progressively, with full results in 16 weeks.